LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 93 filers reported holding LION BIOTECHNOLOGIES INC in Q3 2016. The put-call ratio across all filers is 1.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $327,000 | – | 40,409 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 3,232,416 | $26,183,000 | 12.58% |
Avoro Capital Advisors LLC | 4,338,557 | $35,142,000 | 7.81% |
FRAZIER MANAGEMENT LLC | 774,720 | $6,275,000 | 5.00% |
Broadfin Capital, LLC | 3,170,759 | $25,683,000 | 2.50% |
Perceptive Advisors | 3,611,976 | $29,257,000 | 2.03% |
Ghost Tree Capital, LLC | 700,000 | $5,670,000 | 1.64% |
Opaleye Management Inc. | 260,000 | $2,106,000 | 1.41% |
Rhenman & Partners Asset Management AB | 650,000 | $5,265,000 | 0.94% |
QVT Financial LP | 1,598,309 | $12,946,000 | 0.89% |
Cormorant Asset Management, LP | 505,941 | $4,098,000 | 0.58% |